CESSA logo

Cessatech A/S Stock Price

NGM:CESSA Community·DKK 283.1m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

CESSA Share Price Performance

DKK 15.24
3.44 (29.15%)
DKK 15.24
3.44 (29.15%)
Price DKK 15.24

CESSA Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Moderate risk with adequate balance sheet.

5 Risks
0 Rewards

Cessatech A/S Key Details

-DKK 4.6m

Revenue

DKK 0

Cost of Revenue

-DKK 4.6m

Gross Profit

DKK 12.7m

Other Expenses

-DKK 17.3m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-0.93
100.00%
377.19%
0%
View Full Analysis

About CESSA

Founded
2020
Employees
4
CEO
Jes Trygved
WebsiteView website
www.cessatech.com

Cessatech A/S, a pharmaceutical company, develops and commercializes medicines for the treatment of pediatric acute pain in Denmark. The company’s lead product is CT001, an analgesic nasal spray for the treatment of acute and planned painful procedures in children. It also develops CT002, a nasal spray for sedative procedures for children from 0-17 years of age; and CT003, a local anesthetic gel. The company has a collaboration and license agreement with Ventis Pharma Corporation to develop and formulate pain management therapies. Cessatech A/S was founded in 2020 and is based in Copenhagen, Denmark.

Recent CESSA News & Updates

Cessatech (NGM:CESSA) Is In A Good Position To Deliver On Growth Plans

Nov 01
Cessatech (NGM:CESSA) Is In A Good Position To Deliver On Growth Plans

Recent updates

No updates